Published in Mol Pharm on February 02, 2009
Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery. Biomaterials (2012) 1.59
P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells. Nanomedicine (Lond) (2012) 1.14
Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery. Biomaterials (2012) 1.09
Polymers in small-interfering RNA delivery. Nucleic Acid Ther (2011) 1.09
Strategies for targeted nonviral delivery of siRNAs in vivo. Trends Mol Med (2009) 1.04
Concepts in in vivo siRNA delivery for cancer therapy. J Cell Physiol (2009) 0.98
Phospholipid-polyethylenimine conjugate-based micelle-like nanoparticles for siRNA delivery. Drug Deliv Transl Res (2011) 0.92
Molecular dynamics simulations of DNA/PEI complexes: effect of PEI branching and protonation state. Biophys J (2011) 0.85
Trilayer micelles for combination delivery of rapamycin and siRNA targeting Y-box binding protein-1 (siYB-1). Biomaterials (2013) 0.81
Phospholipid-modified polyethylenimine-based nanopreparations for siRNA-mediated gene silencing: implications for transfection and the role of lipid components. Nanomedicine (2013) 0.80
Light-mediated activation of siRNA Release in diblock copolymer assemblies for controlled gene silencing. Adv Healthc Mater (2014) 0.80
STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo. Transl Oncol (2011) 0.78
Micelle-like nanoparticles as carriers for DNA and siRNA. Mol Pharm (2015) 0.77
Effective small interfering RNA delivery in vitro via a new stearylated cationic peptide. Int J Nanomedicine (2015) 0.76
Preparation of Effective and Safe Gene Carriers by Grafting Alkyl Chains to Generation 5 Polypropyleneimine. AAPS PharmSciTech (2015) 0.76
Synthesis and evaluation of tetramethylguanidinium-polyethylenimine polymers as efficient gene delivery vectors. Biomed Res Int (2014) 0.75
Poly(ester amine) Composed of Polyethylenimine and Pluronic Enhance Delivery of Antisense Oligonucleotides In Vitro and in Dystrophic mdx Mice. Mol Ther Nucleic Acids (2016) 0.75
Non-covalent complexes of folic acid and oleic acid conjugated polyethylenimine: An efficient vehicle for antisense oligonucleotide delivery. Colloids Surf B Biointerfaces (2015) 0.75
Amphiphilic block copolymers for drug delivery. J Pharm Sci (2003) 1.86
A simple cellular automaton model for influenza A viral infections. J Theor Biol (2005) 1.54
Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. Adv Drug Deliv Rev (2002) 1.50
Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin. ACS Nano (2011) 1.46
Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine (2004) 1.44
Polymeric micelles for drug delivery. Expert Opin Drug Deliv (2006) 1.35
Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol. Cancer Chemother Pharmacol (2008) 1.33
P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. Curr Cancer Drug Targets (2013) 1.29
'Magic bullets' for bone diseases: progress in rational design of bone-seeking medicinal agents. Chem Soc Rev (2006) 1.29
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations. Adv Drug Deliv Rev (2011) 1.22
Nanoparticulate systems for growth factor delivery. Pharm Res (2009) 1.18
Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity. Vaccine (2008) 1.17
Randomized, double-blind clinical trial of two different modes of positive airway pressure therapy on adherence and efficacy in children. J Clin Sleep Med (2012) 1.17
Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo. J Biomed Mater Res (2002) 1.16
Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A. J Control Release (2005) 1.14
Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J Biomed Mater Res A (2008) 1.13
Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. J Control Release (2005) 1.10
"Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells. J Immunother (2007) 1.09
Puberty and upper airway dynamics during sleep. Sleep (2008) 1.09
High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin. Biomed Chromatogr (2007) 1.08
Supramolecular assemblies in functional siRNA delivery: where do we stand? Biomaterials (2011) 1.07
Predictors of positive airway pressure therapy adherence in children: a prospective study. J Clin Sleep Med (2012) 1.06
Polymeric micelles for drug targeting. J Drug Target (2007) 1.04
The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin. Biomaterials (2009) 1.04
Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses. J Drug Target (2003) 1.04
In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localisation. Eur J Pharm Biopharm (2005) 1.03
Evolution of the vertebrate gene regulatory network controlled by the transcriptional repressor REST. Mol Biol Evol (2009) 1.02
Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. Biomaterials (2008) 1.01
Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution. Biomaterials (2005) 1.00
The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide). J Control Release (2002) 1.00
Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line. Mol Pharm (2011) 0.98
The effect of block copolymer structure on the internalization of polymeric micelles by human breast cancer cells. Colloids Surf B Biointerfaces (2005) 0.98
Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery. Biomaterials (2009) 0.97
Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro. Pharm Res (2002) 0.97
Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI-124 in a mouse melanoma tumor model. Immunol Cell Biol (2008) 0.97
In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments. Clin Orthop Relat Res (2006) 0.97
A simple and rapid nonviral approach to efficiently transfect primary tissue-derived cells using polyethylenimine. Nat Protoc (2012) 0.97
Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating. Pharm Res (2008) 0.96
Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres. J Control Release (2002) 0.96
Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells. J Biomed Mater Res A (2008) 0.96
Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery. Curr Drug Deliv (2004) 0.96
Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles. J Biomed Mater Res A (2007) 0.95
Rapid eye movement latency in children and adolescents. Pediatr Neurol (2008) 0.94
Aliphatic lipid substitution on 2 kDa polyethylenimine improves plasmid delivery and transgene expression. Mol Pharm (2009) 0.93
Osteogenic differentiation of human mesenchymal stem cells cultured with dexamethasone, vitamin D3, basic fibroblast growth factor, and bone morphogenetic protein-2. Connect Tissue Res (2011) 0.93
Evaluation of nose-only aerosol inhalation chamber and comparison of experimental results with mathematical simulation of aerosol deposition in mouse lungs. J Pharm Sci (2003) 0.92
Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading. Int J Pharm (2006) 0.92
Poly-L-lysine-coated albumin nanoparticles: stability, mechanism for increasing in vitro enzymatic resilience, and siRNA release characteristics. Acta Biomater (2010) 0.92
Noggin suppression decreases BMP-2-induced osteogenesis of human bone marrow-derived mesenchymal stem cells in vitro. J Cell Biochem (2012) 0.92
Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses. J Clin Virol (2004) 0.91
Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses. J Pharm Pharmacol (2006) 0.90
Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy. Mol Pharm (2010) 0.90
A comparative evaluation of poly-L-lysine-palmitic acid and Lipofectamine 2000 for plasmid delivery to bone marrow stromal cells. Biomaterials (2007) 0.90
Block copolymer micelles for the encapsulation and delivery of amphotericin B. Pharm Res (2002) 0.90
Engineering of amphiphilic block copolymers for polymeric micellar drug and gene delivery. J Control Release (2011) 0.90
Recent attempts at RNAi-mediated P-glycoprotein downregulation for reversal of multidrug resistance in cancer. Med Res Rev (2011) 0.90
Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles. Pharm Res (2011) 0.89
Cellular uptake pathways of lipid-modified cationic polymers in gene delivery to primary cells. Biomaterials (2012) 0.89
Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration. J Drug Target (2010) 0.89
Effect of sleep stage on breathing in children with central hypoventilation. J Appl Physiol (1985) (2008) 0.89
Thermodynamics of polyethylenimine-DNA binding and DNA condensation. Biophys J (2010) 0.89
Palmitic acid substitution on cationic polymers for effective delivery of plasmid DNA to bone marrow stromal cells. J Biomed Mater Res A (2007) 0.89
Effects of size and topology of DNA molecules on intracellular delivery with non-viral gene carriers. BMC Biotechnol (2008) 0.89
Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells. Pharm Res (2008) 0.88
Application of molecular dynamics simulation to predict the compatability between water-insoluble drugs and self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) block copolymers. Biomacromolecules (2008) 0.87
The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine. Biomaterials (2009) 0.87
Disposition of drugs in block copolymer micelle delivery systems: from discovery to recovery. Clin Pharmacokinet (2008) 0.86
STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response. Mol Pharm (2010) 0.86
Development of a sensitive and specific liquid chromatography/mass spectrometry method for the quantification of cucurbitacin I (JSI-124) in rat plasma. J Pharm Pharm Sci (2006) 0.86
Peptide arrays for screening cancer specific peptides. Anal Chem (2010) 0.86
Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles. J Drug Target (2010) 0.86
Molecular dynamics simulations of DNA/PEI complexes: effect of PEI branching and protonation state. Biophys J (2011) 0.85
Bisphosphonate-decorated lipid nanoparticles designed as drug carriers for bone diseases. J Biomed Mater Res A (2011) 0.85
Pharmacokinetics and bone formation by BMP-2 entrapped in polyethylenimine-coated albumin nanoparticles. Biomaterials (2009) 0.85
Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers. Macromol Biosci (2011) 0.85